Squarepoint Ops LLC Ocugen, Inc. Transaction History

Squarepoint Ops LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.5 - $1.83 $71,696 - $262,409	143,393 New	143,393 $235,000
Q4 2022 Feb 14, 2023	SELL	$1.11 - $1.87 $82,909 - $139,675	-74,693 Reduced 73.52%	26,900 $34,000
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.1 $137,362 - $243,328	78,493 Added 339.8%	101,593 $181,000
Q2 2022 Aug 15, 2022	BUY	$1.83 - $3.45 $42,273 - $79,695	23,100 New	23,100 $52,000
Q1 2022 May 16, 2022	SELL	$2.34 - $4.72 $230,733 - $465,410	-98,604 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.38 - $15.67 $328,745 - $1.18 Million	75,056 Added 318.74%	98,604 $449,000
Q3 2021 Nov 15, 2021	SELL	$6.36 - $8.51 $605,929 - $810,764	-95,272 Reduced 80.18%	23,548 $169,000
Q2 2021 Aug 16, 2021	BUY	$5.52 - $15.68 $33,936 - $96,400	6,148 Added 5.46%	118,820 $954,000
Q1 2021 May 17, 2021	SELL	$1.66 - $15.81 $376,785 - $3.59 Million	-226,979 Reduced 66.83%	112,672 $765,000
Q4 2020 Feb 16, 2021	BUY	$0.28 - $2.6 $95,102 - $883,092	339,651 New	339,651 $622,000
Q2 2020 Aug 14, 2020	SELL	$0.22 - $0.46 $7,679 - $16,058	-34,909 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.26 - $0.73 $9,076 - $25,483	34,909 New	34,909 $10,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $175M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.